Well “they” named this DRUG correctly. “Neuro-rotten”. Gabapentin marketed under the name Neurontin initially as an anti-seizure medicine and was first approved in 1993.
Serious side-effects DO INCLUDE increased risk of suicide, aggressive behavior reduce mental or cognitive ability including memory. During the onset attempting to gain market share and wide spread acceptance Park-Davis a sub-company of Pfizer used a number of, in my opinion, questionable techniques to encourage doctors to push the drug for disorders not approved for use.
Drug Dealers Of America
Drug dealers bribing Profession Health Care Providers to sell more drugs lead to multiple lawsuits by patience who were harmed and ultimately where settled with multi-million dollar “go away” settlements and millions of dollars in “pay us” fines, before you pay us and let us approve it for first fees.
In 2010 the American Headache Society (AHS) and American Academy of Neurology (AAN) guidelines classify gabapentin as a drug with “insufficient data to support or refute use for migraine prophylaxis.“[1] Furthermore, a 2013 Cochrane review concluded that gabapentin was not useful for the prevention of episodic migraine in adults.*[2].
Gabapentin uses the brains GABA pathways to gain access to the synopitic clef and affect neurotransmission. Please Continue reading “The Brain: Gabapentin (Neurontin)”